Neuroscientific Biopharmaceuticals Ltd (NSB) — Cash Flow Reinvestment Rate

Latest as of June 2024: 0.00x

Neuroscientific Biopharmaceuticals Ltd (NSB) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting AU$1.82K (capex AU$1.82K ) from operating cash flow of AU$1.62 Million. Check NSB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

AU$1.82K

Capex + Investments

Operating Cash Flow

AU$1.62 Million

AUD

Capital Expenditures

AU$1.82K

AUD

Neuroscientific Biopharmaceuticals Ltd Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for Neuroscientific Biopharmaceuticals Ltd across 1 annual periods. Explore debt repayment capacity of Neuroscientific Biopharmaceuticals Ltd to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Neuroscientific Biopharmaceuticals Ltd (2024–2024)

Year-by-year capital reinvestment analysis for Neuroscientific Biopharmaceuticals Ltd. For live market cap and broader valuation context, see Neuroscientific Biopharmaceuticals Ltd market cap and net worth.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2024	0.08x	AU$3.63K	AU$44.25K	AU$1.81K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow